Establishing a Care Continuum for Cardiometabolic Conditions for Patients with Serious Mental Illness

Overview

Journal Curr Cardiol Rep

Publisher Current Science

Specialty Cardiology & Vascular Diseases

Date 2023 Feb 27

PMID 36847991

Authors

Karly A Murphy

Gail L Daumit

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Addressing cardiometabolic risk factors in persons with serious mental illness requires early screening and proactive medical management in both medical and mental health settings.

Recent Findings: Cardiovascular disease remains the leading cause of death for persons with serious mental illness (SMI), such as schizophrenia or bipolar disorder, much of which is driven by a high prevalence of metabolic syndrome, diabetes, and tobacco use. We summarize barriers and recent approaches to screening and treatment for metabolic cardiovascular risk factors within physical health and specialty mental health settings. Incorporating system-based and provider-level support within physical health and psychiatric clinical settings should contribute to improvement for screening, diagnosis, and treatment for cardiometabolic conditions for patients with SMI. Targeted education for clinicians and leveraging multi-disciplinary teams are important first steps to recognize and treat populations with SMI at risk of CVD.

Citing Articles

The Impact of Structural Integration on Clinical Outcomes among Individuals with Serious Mental Illness and Chronic Illness.

Matthews E, Lushin V, Macneal E, Marcus S Community Ment Health J. 2024; 60(7):1372-1379.

PMID: 38850504 PMC: 11408560. DOI: 10.1007/s10597-024-01293-4.

References

Druss B, Singh M, von Esenwein S, Glick G, Tapscott S, Tucker S . Peer-Led Self-Management of General Medical Conditions for Patients With Serious Mental Illnesses: A Randomized Trial. Psychiatr Serv. 2018; 69(5):529-535. PMC: 5930018. DOI: 10.1176/appi.ps.201700352. View

Rossom R, Crain A, OConnor P, Waring S, Hooker S, Ohnsorg K . Effect of Clinical Decision Support on Cardiovascular Risk Among Adults With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022; 5(3):e220202. PMC: 8902652. DOI: 10.1001/jamanetworkopen.2022.0202. View

Switaj P, Anczewska M, Chrostek A, Sabariego C, Cieza A, Bickenbach J . Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatry. 2012; 12:193. PMC: 3539983. DOI: 10.1186/1471-244X-12-193. View

Murphy K, Daumit G, Stone E, McGinty E . Physical health outcomes and implementation of behavioural health homes: a comprehensive review. Int Rev Psychiatry. 2019; 30(6):224-241. PMC: 6499693. DOI: 10.1080/09540261.2018.1555153. View

Vistorte A, Ribeiro W, Jaen D, Jorge M, Evans-Lacko S, de Jesus Mari J . Stigmatizing attitudes of primary care professionals towards people with mental disorders: A systematic review. Int J Psychiatry Med. 2018; 53(4):317-338. DOI: 10.1177/0091217418778620. View

McGinty E, Stone E, Daumit G . Serious Mental Illness in Primary Care: a National Physician Survey. J Gen Intern Med. 2020; 36(3):833-835. PMC: 7947081. DOI: 10.1007/s11606-020-05950-8. View

Dalcin A, Jerome G, Appel L, Dickerson F, Wang N, Miller E . Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention. Front Psychiatry. 2019; 9:786. PMC: 6375886. DOI: 10.3389/fpsyt.2018.00786. View

Nasrallah H, Meyer J, Goff D, McEvoy J, Davis S, Stroup T . Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006; 86(1-3):15-22. DOI: 10.1016/j.schres.2006.06.026. View

Scharf D, Eberhart N, Hackbarth N, Horvitz-Lennon M, Beckman R, Han B . Evaluation of the SAMHSA Primary and Behavioral Health Care Integration (PBHCI) Grant Program: Final Report. Rand Health Q. 2017; 4(3):6. PMC: 5396204. View

10.

Dehon E, Weiss N, Jones J, Faulconer W, Hinton E, Sterling S . A Systematic Review of the Impact of Physician Implicit Racial Bias on Clinical Decision Making. Acad Emerg Med. 2017; 24(8):895-904. DOI: 10.1111/acem.13214. View

11.

Dickerson F, Schroeder J, Katsafanas E, Khushalani S, Origoni A, Savage C . Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity. Psychiatr Serv. 2017; 69(2):147-153. DOI: 10.1176/appi.ps.201700118. View

12.

Daneshvari N, Mojtabai R, Eaton W, Cullen B, Rodriguez K, Spivak S . Symptom Severity and Care Delay among Patients with Serious Mental Illness. J Health Care Poor Underserved. 2021; 32(3):1312-1319. DOI: 10.1353/hpu.2021.0134. View

13.

Cohen S, Bostwick J, Marshall V, Kruse K, Dalack G, Patel P . The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics. J Clin Pharm Ther. 2020; 45(6):1398-1404. DOI: 10.1111/jcpt.13236. View

14.

Blixen C, Perzynski A, Kanuch S, Dawson N, Kaiser D, Lawless M . Training peer educators to promote self-management skills in people with serious mental illness (SMI) and diabetes (DM) in a primary health care setting. Prim Health Care Res Dev. 2014; 16(2):127-37. PMC: 4375542. DOI: 10.1017/S1463423614000176. View

15.

Van Dort B, Zheng W, Sundar V, Baysari M . Optimizing clinical decision support alerts in electronic medical records: a systematic review of reported strategies adopted by hospitals. J Am Med Inform Assoc. 2020; 28(1):177-183. PMC: 7810441. DOI: 10.1093/jamia/ocaa279. View

16.

Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S, Galletly C . The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019; 6(8):675-712. DOI: 10.1016/S2215-0366(19)30132-4. View

17.

Daumit G, Stone E, Kennedy-Hendricks A, Choksy S, Marsteller J, McGinty E . Care Coordination and Population Health Management Strategies and Challenges in a Behavioral Health Home Model. Med Care. 2018; 57(1):79-84. PMC: 6289741. DOI: 10.1097/MLR.0000000000001023. View

18.

De Hert M, Detraux J, van Winkel R, Yu W, Correll C . Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011; 8(2):114-26. DOI: 10.1038/nrendo.2011.156. View

19.

Vanderlip E, Henwood B, Hrouda D, Meyer P, Monroe-DeVita M, Studer L . Systematic Literature Review of General Health Care Interventions Within Programs of Assertive Community Treatment. Psychiatr Serv. 2016; 68(3):218-224. DOI: 10.1176/appi.ps.201600100. View

20.

Mueser K, McGurk S . Schizophrenia. Lancet. 2004; 363(9426):2063-72. DOI: 10.1016/S0140-6736(04)16458-1. View